Familial hypercholesterolaemia: A global call to arms

Atherosclerosis

Volumn 243, Issue 1, 2015, Pages 257-259

  Vallejo Vaz, Antonio J ^a   Kondapally Seshasai, Sreenivasa Rao ^b   Cole, Della ^b   Hovingh, G Kees ^c   Kastelein, John J P ^c   Mata, Pedro ^d   Raal, Frederick J ^e   Santos, Raul D ^f   Soran, Handrean ^g   Watts, Gerald F ^h   Abifadel, Marianne ⁱ   Aguilar Salinas, Carlos A ^j   Akram, Asif ^a   Alnouri, Fahad ^k   Alonso, Rodrigo ^l   Al Rasadi, Khalid ^m   Banach, Maciej ⁿ   Bogsrud, Martin P ^o   Bourbon, Mafalda ^p   Bruckert, Eric ^q   Car, Josip ^a,r   Corral, Pablo ^s   Descamps, Olivier ^t   Dieplinger, Hans ^u   Durst, Ronen ^v   Freiberger, Tomas ^w   Gaspar, Isabel M ^p   Genest, Jaques ^x   Harada Shiba, Mariko ^y   Jiang, Lixin ^z   Kayikcioglu, Meral ^aa   Lam, Carolyn S P ^ab   Latkovskis, Gustavs ^ac   Laufs, Ulrich ^ad   Liberopoulos, Evangelos ^ae   Nilsson, Lennart ^af   Nordestgaard, Børge G ^ag   O'Donoghue, John M ^a   Sahebkar, Amirhossein ^ah   Schunkert, Heribert ^ai   Shehab, Abdulla ^aj   Stoll, Mario ^ak   Su, Ta Chen ^al   Susekov, Andrey ^am   Widén, Elisabeth ^an   Catapano, Alberico L ^ao   Ray, Kausik K ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Medicina Interna   (Spain)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ SAINT JOSEPH UNIVERSITY   (Lebanon)

^j INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^k Prince Sultan Cardiac Centre   (Saudi Arabia)

^l CLÍNICA LAS CONDES   (Chile)

^m SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

ⁿ MEDICAL UNIVERSITY OF LODZ   (Poland)

^o National Advisory Unit on Familial Hypercholesterolemia   (Norway)

^p UNIVERSITY OF LISBON   (Portugal)

^q Endocrinologie métabolisme et prevention cardiovasculaire Institut E3M et IHU cardiométabolique ICAN HôpitalPitiéSalpêtrière   (France)

^r NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^s FASTA University School of Medicine   (Argentina)

^t Hospital de Jolimont   (Belgium)

^u INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^v HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^w MASARYK UNIVERSITY   (Czech Republic)

^x MCGILL UNIVERSITY   (Canada)

^y National Cerebral and Cardiovascular Center Research Institute   (Japan)

^z National Center for Cardiovascular Diseases   (China)

^aa EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^ab DEPARTMENT OF CARDIOLOGY   (Singapore)

^ac PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^ad SAARLAND UNIVERSITY   (Germany)

^ae UNIVERSITY OF IOANNINA   (Greece)

^af LINKÖPING UNIVERSITY   (Sweden)

^ag GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^ah MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ai TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^aj UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^ak Cardiovascular Genetic Laboratory Cardiovascular Health Commission   (Uruguay)

^al NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^am INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^an UNIVERSITY OF HELSINKI   (Finland)

^ao UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

Familial hypercholesterolaemia

Indexed keywords

ARTICLE; DISEASE REGISTRY; EUROPE; FAMILIAL HYPERCHOLESTEROLEMIA; HEALTH PROGRAM; HUMAN; MEDICAL SOCIETY; PREVALENCE; PRIORITY JOURNAL; GENETICS; HEALTH; HETEROZYGOTE; HYPERLIPOPROTEINEMIA TYPE II; MUTATION;

LOW DENSITY LIPOPROTEIN RECEPTOR;

EUROPE; GLOBAL HEALTH; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MUTATION; RECEPTORS, LDL; SOCIETIES, MEDICAL;

EID: 84942509791     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.09.021     Document Type: Article

References (12)

1. Nordestgaard B.G., Chapman M.J., Humphries S.E., et al. Familial hypercholesterolemia is underdiagnosed and undertreated in the general population: guidance to clinicians to prevent coronary artery disease. Consensus Statement Eur. Atheroscler. Soc. Eur. Heart J 2013, 34:3478-3490.
2. Cuchel M., Bruckert E., Ginsberg H.N., et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A Position Pap. Consensus Panel Fam. Hypercholesterolaemia Eur. Atheroscler. Soc. Eur. Heart J 2014, 35(32):2146-2157.
3. Wiegman A., Gidding S.S., Watts G.F., et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur. Heart J. 2015, pii: ehv157, First published online: 25 May 2015. 10.1093/eurheartj/ehv157.
4. Do R., Stitziel N.O., Won H.H., et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature 2015, 518(7537):102-106.
5. Huijgen R., Kindt I., Defesche J.C., Kastelein J.J. Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants. Eur. Heart J. 2012, 33(18):2325-2330.
6. Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J. Clin. Endocrinol. Metab. 2012, 97(11):3956-3964.
7. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am. J. Epidemiol. 2004, 160(5):407-420.
8. Sjouke B., DM1 Kusters, Kindt I., et al. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome. Eur. Heart J. 2015, 36(9):560-565.
9. Neil A., Cooper J., Betteridge J., et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur. Heart J. 2008, 29:2625-2633.
10. Versmissen J., Oosterveer D.M., Yazdanpanah M., et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008, 337:a2423.
11. World Health Organization (WHO) International Classification of Diseases (ICD) - 10.Version 2015, Last consult 20 August, 2015. http://apps.who.int/classifications/icd10/browse/2015/en.
12. Ademi Z., Watts G.F., Juniper A., Liew D. A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia. Int. J. Cardiol. 2013, 167(6):2391-2396.